AbstractWe compared the sensitivity of bone marrow biopsy to blood flow cytometry in detecting minimal residual disease (MRD) in 29 patients with chronic lymphocytic leukemia (CLL) in clinical remission after treatment. These results demonstrate that flow cytometry is more sensitive than bone marrow biopsy in detecting MRD and in predicting relapse in CLL.
Figures & Tables
Vol. 91 No. 6 (2006): June, 2006 : Comparative Studies
Ferrata Storti Foundation, Pavia, Italy
Statistics from Altmetric.com